Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Conformational disease

R W Carrell1, D A Lomas

  • 1Department of Haematology, University of Cambridge, MRC Centre, Addenbrooke's Hospital, UK.

Lancet (London, England)
|July 12, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A genome-wide analysis of the response to inhaled β2-agonists in chronic obstructive pulmonary disease.

The pharmacogenomics journal·2015
Same author

Molecular pathogenesis of alpha-1-antitrypsin deficiency.

Revue des maladies respiratoires·2014
Same author

The endoplasmic reticulum stress marker CHOP predicts survival in malignant mesothelioma.

British journal of cancer·2013
Same author

The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency.

International journal of chronic obstructive pulmonary disease·2012
Same author

Genetic association between human chitinases and lung function in COPD.

Human genetics·2011
Same author

ANCA-associated vasculitis is linked to carriage of the Z allele of α₁ antitrypsin and its polymers.

Annals of the rheumatic diseases·2011
Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026
Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026
Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026
Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026
Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026
Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026
See all related articles

Diverse neurological disorders, including dementias and encephalopathies, share a common mechanism involving protein misfolding and aggregation. Understanding these molecular processes aids in developing targeted investigations and therapies.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathology

Background:

  • Many prevalent neurological disorders, such as dementias and encephalopathies, share a common underlying pathological mechanism.
  • This mechanism involves the abnormal unfolding and subsequent aggregation of specific proteins within the brain.

Purpose of the Study:

  • To elucidate the shared molecular mechanism driving diverse neurological disorders.
  • To explore how protein aggregation and stress influence disease onset and progression.
  • To identify potential avenues for rational therapeutic interventions.

Main Methods:

  • The study focuses on the molecular-level understanding of protein misfolding and aggregation.
  • It examines the role of gradual accumulation of protein aggregates.

Related Experiment Videos

  • It investigates the impact of stress in accelerating aggregate formation.

    • Main Results:

    • A unifying disease mechanism involving protein misfolding and aggregation is proposed for diverse neurological conditions.
    • The late or episodic onset of clinical symptoms is explained by aggregate accumulation and stress-induced acceleration.
    • Molecular insights provide a basis for novel diagnostic and therapeutic strategies.

    Conclusions:

    • Abnormal protein dynamics are central to a range of prevalent neurological diseases.
    • Understanding these molecular events offers a pathway to developing more effective treatments.
    • This research opens new prospects for rational investigation and therapy in neurodegenerative diseases.